Medicare Enrolled
Dr. Jason Rothman, M.D.
Urology Physician · Durham, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rothman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rothman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rothman
Dr. Jason Rothman is an urology physician in Durham, NC, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rothman performed 4,441 Medicare services across 2,033 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rothman received a total of $13,236 from 73 pharmaceutical and/or device companies across 624 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rothman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 20% volume in NC
$13,236 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,441
Medicare services
Top 20% in NC for urology physician
2,033
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~261 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,800 | $0 | $2 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
708 | $2 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
380 | $58 | $96 |
| PSA test (prostate cancer screening) | 360 | $18 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
316 | $85 | $137 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
311 | $7 | $11 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
90 | $170 | $257 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $137 | $250 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
76 | $21 | $32 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $110 | $176 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
45 | $47 | $59 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
37 | $102 | $144 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
35 | $25 | $28 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
26 | $72 | $118 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
24 | $26 | $35 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
19 | $182 | $255 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
18 | $3 | $4 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
17 | $196 | $352 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
16 | $80 | $210 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
14 | $38 | $60 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
13 | $60 | $105 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
12 | $205 | $335 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
50.1% medium
49.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,236
Total received (2018-2024)
Avg $1,891/year across 7 years
Top 12% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
624
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,051 (98.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$100 (0.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$85 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,260
2023
$1,979
2022
$2,767
2021
$2,093
2020
$718
2019
$1,767
2018
$1,652
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Dendreon Pharmaceuticals LLC
$472
Sumitomo Pharma America, Inc.
$341
Janssen Biotech, Inc.
$280
PROCEPT BioRobotics Corporation
$173
PROGENICS PHARMACEUTICALS, INC.
$113
UROGEN PHARMA, INC.
$96
Bayer Healthcare Pharmaceuticals Inc.
$95
Endo USA, Inc.
$92
PFIZER INC.
$83
Ferring Pharmaceuticals Inc.
$80
Endo Pharmaceuticals Inc.
$74
ABBVIE INC.
$71
Novartis Pharmaceuticals Corporation
$71
Teleflex LLC
$47
Merck Sharp & Dohme LLC
$47
ConvaTec Inc.
$35
Boston Scientific Corporation
$20
Antares Pharma, Inc.
$20
Olympus America Inc.
$19
Ethicon US, LLC
$16
Axonics, Inc.
$13
Top 3 companies account for 48.3% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$1,933
Janssen Biotech, Inc.
$1,673
Astellas Pharma US Inc
$1,368
Sumitomo Pharma America, Inc.
$782
Teleflex LLC
$732
PFIZER INC.
$592
Endo Pharmaceuticals Inc.
$463
Myovant Sciences Inc.
$423
Ferring Pharmaceuticals Inc.
$224
Antares Pharma, Inc.
$224
Bayer HealthCare Pharmaceuticals Inc.
$219
UROVANT SCIENCES INC
$213
PROCEPT BioRobotics Corporation
$208
Bayer Healthcare Pharmaceuticals Inc.
$177
Amgen Inc.
$175
NeoTract Inc.
$175
AbbVie Inc.
$170
Boston Scientific Corporation
$168
Avadel Specialty Pharmaceuticals, LLC
$167
UROGEN PHARMA, INC.
$155
Clarus Therapeutics Inc.
$151
ABBVIE INC.
$146
180 Medical, Inc.
$144
GENZYME CORPORATION
$131
Ethicon US, LLC
$129
PROGENICS PHARMACEUTICALS, INC.
$113
Janssen Scientific Affairs, LLC
$112
UroGen Pharma, Inc.
$110
Merck Sharp & Dohme LLC
$106
Novartis Pharmaceuticals Corporation
$100
COMSORT, Inc
$100
Merck Sharp & Dohme Corporation
$100
Photocure Inc
$100
Endo USA, Inc.
$92
BOSTON SCIENTIFIC CORPORATION
$91
TOLMAR Pharmaceuticals, Inc.
$90
Caldera Medical, Inc
$81
AstraZeneca Pharmaceuticals LP
$76
AbbVie, Inc.
$76
ConvaTec Inc.
$69
Supernus Pharmaceuticals, Inc.
$65
Olympus America Inc.
$63
Janssen Products, LP
$60
Sun Pharmaceutical Industries Inc.
$59
Mission Pharmacal Company
$52
Progenics Pharmaceuticals, Inc.
$51
Laborie Medical Technologies Corp.
$51
Blue Earth Diagnostics Limited
$50
Allergan, Inc.
$31
Axonics, Inc.
$30
Tolmar, Inc.
$28
Coloplast Corp
$25
Smith+Nephew, Inc.
$23
ACCORD HEALTHCARE, INC.
$20
COLOPLAST CORP
$19
Ambu Inc.
$19
RGH Enterprises, Inc.
$17
Travere Therapeutics, Inc.
$16
Axonics Modulation Technologies, Inc.
$15
Retrophin, Inc.
$15
SRS Medical Systems, Inc.
$15
Baudax Bio Inc.
$15
Medtronic, Inc.
$15
Davol Inc.
$14
Aytu BioScience, Inc
$14
SUN PHARMACEUTICAL INDUSTRIES INC.
$13
Hollister Incorporated
$13
Rochester Medical Corporation
$12
DENTSPLY IH Inc.
$12
Allergan Inc.
$12
Egalet US Inc
$12
Zyla Life Sciences
$11
NxThera, Inc.
$10
Top 3 companies account for 37.6% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ABIRATERONE ACETATE · ADSTILADRIN · ALTIS · ANJESO · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · ARISTA AH FLEXITIP · Axonics · Axonics r-SNM System · Axumin · BOTOX · CAMCEVI · CLENPIQ · CURE CATHETER · CURE ULTRA CATHETER · CYSVIEW · Colorise · Cysview · DERMABOND PRINEO · Desara · Digital Flexible Ureteroscopes · EDEX · ELIGARD · ERLEADA · ETHICON · Erleada · FIRMAGON · GEMTESA · GENERAL EMBOLICS · GENERAL - KIDNEY STONE DISEASE · GENTLECATH · GREENLIGHT · GentleCath · INTERSTIM · Infyna Chic · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PLUVICTO · PROVENGE · PYLARIFY · Prineo 42 · Prolia · REZUM · Rezum · SPRIX · STRATAFIX · STRAVIX · SURGICEL NU-KNIT · SUTENT · SWISS LITHOCLAST TRILOGY · ShockPulse - SE · TITAN · TOVIAZ · Thiola · Titan · UROLIFT · Uribel · UroCuff · UroLift · UroLift System · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · YONSA · ZYTIGA · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
73
Per 100K population
22.2
County median income
$79,501
Nearest hospital
NORTH CAROLINA SPECIALTY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rothman is a clinical cardiology specialist, with above-average Medicare volume (top 20% in NC), with low-engagement industry engagement in the top 12% of NC peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rothman experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Rothman performed 1,800 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rothman receive payments from pharmaceutical companies?
Yes. Dr. Rothman received a total of $13,236 from 73 companies across 624 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rothman's costs compare to other urology physicians in Durham?
Dr. Rothman's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rothman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Durham
Browse urology physicians in Durham ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology